Study to Evaluate Safety, Tolerability, Efficacy and Pharmacokinetics of ASC10 in Mild to Moderate COVID-19 Patients
Clinical trial NCT05596045 · WITHDRAWN
Trial details
- NCT number
- NCT05596045
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-28
- Primary completion
- 2023-03-08
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.